Medscape

MHRA Approves UK’s First Nasal Spray for Anaphylaxis

An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). This marks the first time a needle-free ...
News Medical

World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Medscape

MHRA Approves New Immunotherapy for Bladder Cancer

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved nogapendekin alfa inbakicept (Anktiva, ImmunityBio) for use in adults with carcinoma in situ (CIS) non-muscle-invasive ...
Pharmabiz

UK MHRA approves zapomeran mRNA Covid-19 vaccine for immunisation of individuals aged 18 years of age and older

The Medicines and Healthcare products Regulatory Agency (MHRA) has on 2nd January, 2026, approved zapomeran (Kostaive) mRNA Covid-19 vaccine, for the immunisation of individuals aged 18 years of age ...